Steven Barth Discusses Regulatory Hurdles for Strategic Buyers
October 15, 2024
S&P Global
Foley & Lardner LLP partner Steven Barth commented on the regulatory hurdles strategic buyers face in the S&P Global article, “Private equity fuels TMT M&A for 2nd consecutive quarter in Q3.”
“We live in a current regulatory environment where we can no longer provide reliable advance advice to our clients about whether a deal will likely receive regulatory approval,” Barth explained, highlighting that consequentially, transactional attorneys are emphasizing caution when advising clients.
“We like to be right. And on deals that never get submitted for approval, we’re always right,” Barth added.
Barth’s commentary also appeared in the S&P Global article, “Private equity deals regain momentum; buyout shops lead TMT sector M&A.”
People
Related News
July 20, 2026
In the News
Thomas Ferrante Weighs in on CMS’ Proposed Changes to Remote Patient Monitoring Services
Foley & Lardner LLP partner Thomas Ferrante commented on the Centers for Medicare & Medicaid Services’ (CMS) proposed changes to remote physiologic monitoring (RPM) and remote therapeutic monitoring (RTM) in the Report on Medicare Compliance article, “CMS Flips the Script of RPM and RTM in Proposed 2027 MPFS Rule."
July 13, 2026
In the News
Judith Waltz Quoted on OIG Decertification of New York Medicaid Fraud Control Unit
Foley & Lardner LLP partner Judith Waltz was quoted in the Report on Medicare Compliance article, “OPPS Rule Proposes Targeted Reviews of PBDs, New Attestation, More EMTALA Oversight.”
July 13, 2026
In the News
Blake Tengberg Discusses the Evolving Legal Landscape in Utah Business Roundtable
Foley & Lardner LLP partner Blake Tengberg joined leading Utah attorneys for a Utah Business roundtable discussing opportunities and challenges shaping the legal industry.